Comparative profiling of surgically resected primary tumors and their lymph node metastases in small-cell lung cancer
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Semmelweis Egyetem
- Innovációs és Technológiai Minisztérium (UNKP\u201020\u20103)
- Innovációs és Technológiai Minisztérium (UNKP\u201021\u20103)
- Innovációs és Technológiai Minisztérium (UNKP-23-5)
- Innovációs és Technológiai Minisztérium (UNKP-23-3)
- National Research, Development and Innovation Office (FK\u2010143751)
- National Research, Development and Innovation Office (TKP2021\u2010EGA\u201033)
- National Research, Development and Innovation Office (FK-147045)
- National Research, Development and Innovation Office (2020-1.1.6-J\u00D6V\u0150)
- HORIZON EUROPE Framework Programme
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
- International Association for the Study of Lung Cancer
- European Commission (HORIZON-MSCA-2022-SE-01)
- Magyar Tüdőgyógyász Társaság (MPA #2023)
- Magyar Tudományos Akadémia
- Austrian Science Fund (I3522)
- Austrian Science Fund (I3977)
- Austrian Science Fund (I4677)
- Austrian Science Fund (FWF I3522)
- Austrian Science Fund (FWF I3977)
This publication has 54 references indexed in Scilit:
- Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancerVirchows Archiv, 2024
- Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter studyThe Journal of Pathology, 2022
- Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancerCancer Cell, 2021
- Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCancer Cell, 2021
- Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of ImmunotherapyCurrent Treatment Options in Oncology, 2020
- DLL3 is regulated by LIN28B and miR-518d-5p and regulates cell proliferation, migration and chemotherapy response in advanced small cell lung cancerBiochemical and Biophysical Research Communications, 2019
- The human protein atlas: A spatial map of the human proteomeProtein Science, 2017
- MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionCancer Cell, 2017
- ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic ProgramsCell Reports, 2016
- NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomasInternational Journal of Cancer, 2015